期刊文献+

急性冠脉综合征患者发病早期外周血sFlt-1水平及临床意义 被引量:2

Levels and the clinical significance of sFlt-1 levels in the early acute coronary syndrome patients
下载PDF
导出
摘要 目的:探讨急性冠脉综合征(acute coronary syndrome,ACS)患者发病早期外周血可溶性血管内皮生长因子受体1(soluble fms-like tyrosine kinase receptor 1,sFlt-1)水平的变化及临床意义。方法:选取150例在胸痛、胸闷6 h内就诊的患者,根据最终临床诊断其中102例ACS患者入选ACS组,48例排除ACS的患者入选对照组;比较两组患者入院即刻外周血sFlt-1水平,并绘制受试者工作特征(ROC)曲线,计算曲线下面积,分析血浆sFlt-1水平对ACS的诊断效能。结果:ACS患者发病早期的血浆sFlt-1水平(361.7±288.0)pg/m L显著高于对照组[(126.2±49.6)pg/m L,P<0.01];入院即刻采用sFlt-1单点值诊断ACS的ROC曲线下面积为0.852。结论:血浆sFlt-1在ACS发生的早期显著升高,早期检测sFlt-1有助于ACS患者的早期诊治。 Objective: To explore the clinical values of the peripheral soluble fms-like tyrosine kinase receptor 1 (sFlt-1) levels in early acute coronary syndrome(ACS) patients. Methods: A total of 150 patients who were admitted to hospital in six hours after chest pain occurred were recruited and divided into control group (n =48) or acute coronary syndrome group( ACS, n = 102), plasma sFh-1 were detected and compared between the two groups. Receiver operating characteristic (ROC) curve and area under curve (AUC) were analysed with SPSS 20.0 statistical software. Results: The levels of plasma sFlt-1 in ACS group were significantly higher compared with that of the control group [ ( 361. 7 ± 288.0 ) pg/mL vs ( 126.2± 49.6) pg/mL,P 〈 0.01] For the diagnosis of ACS, the AUC of sFlt-1 was 0. 852. Conclusion : Plasma sFh-1 was significantly elevated in the early ACS patients, and it could be one of the earliest sensitive indicators in the diagnosis and risk estimation of ACS.
出处 《江苏大学学报(医学版)》 CAS 2017年第1期58-60,共3页 Journal of Jiangsu University:Medicine Edition
基金 南京医科大学科技发展基金资助项目(2013njmu154) 无锡市医管中心资助项目(YGZXM1517)
关键词 急性冠脉综合征 可溶性血管内皮生长因子受体1 早期诊断 acute coronary syndrome soluble fins-like tyrosine kinase receptor 1 early diagnosis
  • 相关文献

参考文献2

二级参考文献14

  • 1丁士芳,张运,张梅,陈文强,陈玉国,李贵双,纪求尚,刘同涛,周炜.应用血管内超声技术识别冠状动脉粥样斑块[J].中华超声影像学杂志,2005,14(5):325-329. 被引量:16
  • 2Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 3Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part Ⅰ.Circulation,2003,108:1664-1672.
  • 4Mintz GS,Nissen SE,Anderson WD,et al.American College of Cardiology clinical expert consensus document on standards for acquistion,measurements and reporting of intravascular ultrasound studies.J Am Coll Cardiol,2001,37:1478-1492.
  • 5Kotani J,Mintz GS,Castagna MT,et al.Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction.Circulation,2003,107:2889-2893.
  • 6Varnava AM,Mills PG,Davies MJ,et al.Relationship between coronary artery remodeling and plaque vulnerability.Circulation,2002,105:939-943.
  • 7Dollery CM,McEwan JR,Henney AM.Matrix metalloproteinases and cardiovascular disease.Circ Res,1995,77:863-868.
  • 8Higo S,Uematsu M,Yamagishi M,et al.Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction:clinical evidence from distal protection.Circ J,2005,69:1180-1185.
  • 9Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increasing in the coronary circulation in patients with acute coronary syndrome.Am Heart J,2001,141:211-217.
  • 10Schonbeck U,Libby P.CD40 signaling and plaque instability.Circ Res,2001,89:1092-1103.

共引文献2048

同被引文献29

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部